Huapont Pharmaceutical Invests 86 M Yuan In Nutrichem Laboratory
This article was originally published in PharmAsia News
Executive Summary
Chongqing Huapont Pharmaceutical has confirmed that it is injecting 86 million yuan into Beijing Nutrichem Laboratory to become the latter's second largest shareholder. According to the agreement, Nutrichem Laboratory and its related enterprises Shangyu Nutrichem and Nutrichem International will reorganize to come under Huapont. Industry analysts observed that Huapont was attracted by the promising market of Nutrichem Laboratory's products as well as their common background on chiral drug research. The complementary strengths of both companies will help expand their chiral drug business. (Click here for more)